Views on Dishman Pharmaceuticals 1QFY2016 Result - Angel Broking

Views of Ms. Sarabjit Kour Nangra (VP Research - Pharma, Angel Broking)on Dishman Pharmaceuticals 1QFY2016 Result:

"Dishman Pharmaceuticals for 1QFY2016, posted net sales of INR 400cr V/s INR 361.5cr, a yoy growth of 10.6%. The sales growth was driven by CRAMS (INR 251.8cr), a yoy growth of 5.2%, while others (INR 148.1cr) a yoy growth of 21.3%. On the Operating profit, the OPM's came in at 26.0% V/s 20.5% in 1QFY2015, mainly on back of gross margins expansion, which came in at 79.4% V/s 71.1% in 1QFY2015. The deprecation, which dipped by 15.2% yoy, lead the net profit come in at INR 37.8cr V/s INR 23.8cr, a yoy growth of 58.7%. We maintain our BUY with a price target of INR 290."

Shares of DISHMAN PHARMACEUTICALS & CHEMICALS LTD. was last trading in BSE at Rs.222.25 as compared to the previous close of Rs. 209.9. The total number of shares traded during the day was 449629 in over 7753 trades.

The stock hit an intraday high of Rs. 226.5 and intraday low of 208.25. The net turnover during the day was Rs. 97409256.

Source : Equity Bulls

Keywords